Zinier took its overall funding to $120m in a round that included returning investor Qualcomm Ventures, with the cash to go to international growth and product development.

GV was among the investors as long-term care support provider CareBridge emerged from stealth with $40m and two acquisitions.

Abbott has returned for the first close of insulin technology developer Bigfoot Biomedical’s series C round, after backing its $55m series B two years ago.

GV-backed solid tumour treatment developer Pact Pharma has completed an oversubscribed $75m series C round led by Vida Ventures.

Subsidiaries of Astellas and Novartis co-led a round featuring GV and 6 Dimensions Capital that took the cancer drug developer's overall funding to $60m.

Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.

Alibaba has taken part in an $88.3m round for the community e-commerce platform that came five months after its merger with counterpart Niwoning.

Foxconn, Chow Tai Fook, Hogy Medical and Varian Medical have all invested in a round that took the surgical robot developer's total financing to $160m.

The DNA sequencing technology developer, which counts Nan Fung and Lam Research as investors, has added $60m to take its funding to $145m in the last 18 months.

News Corp and its real estate advertising arm, REA Group, supplied $70m in convertible note financing for the property listings platform.